National authority ensuring drug and cosmetic regulation in India.
Throughout history, medical advancements have played a crucial role in safeguarding human life and treating diseases that once posed significant threats to survival. Medicine remains one of humanity's most powerful tools for combating illnesses and improving quality of life. Unlike ordinary consumer products, medicines are highly specific in their use — a particular drug is intended to treat a particular condition. Therefore, the administration of medicines should always be under the guidance of a qualified medical professional, who can advise patients on what to take, how to take it, and when it should be used to ensure effectiveness and avoid adverse side effects. To regulate the manufacture, import, distribution, and sale of drugs and cosmetics in India, the Government of India enacted The Drugs and Cosmetics Act, 1940. This Act lays down comprehensive provisions to ensure that medicines and cosmetics meet required standards of safety, quality, and efficacy. Additionally, the Act extends its regulatory framework to traditional systems of medicine, including Ayurveda, Siddha, and Unani drugs, providing guidelines to ensure quality and safety are maintained.
Under "The Drugs and Cosmetics Act, 1940," the Central Drugs Standard Control Organization (CDSCO) functions as the national regulatory authority responsible for ensuring the safety, efficacy, and quality of drugs in India. The CDSCO grants approvals for the manufacture and sale of drugs, oversees clinical trials, sets and enforces drug standards, and coordinates quality control activities in collaboration with state regulatory authorities.
In addition to regulating drugs, the CDSCO also plays a vital role in the regulation of cosmetics. In December 2020, the Ministry of Health and Family Welfare notified the Cosmetic Rules, 2020, which make it mandatory to obtain a valid licence for the import of cosmetics into India. These rules ensure that imported cosmetic products meet established safety and quality benchmarks before reaching Indian consumers.
The term "drug" in pharmacology refers to any chemical substance, typically of a defined structure, that, when administered to a living organism, produces a specific biological or physiological effect. Proper licensing and regulation are therefore essential.
Under The Drugs and Cosmetics Act, 1940, every individual or entity engaged in the business of manufacturing, distributing, or selling drugs must obtain an appropriate drug licence from the designated licensing authority. The type of licence required depends on the nature of business operations.
A. Retail Sale Drug Licence (Chemist Shop): Retail Drug Licence permits the sale of drugs directly to the end consumer. Retailers may supply medicines to hospitals, dispensaries, educational institutions, or research centres. It is mandatory for all chemist shops or retail outlets dealing in drugs to hold this licence, issued by the State Drug Controller Authority.
Note: A separate bulk licence is needed for wholesale businesses. Retailers cannot be engaged in the wholesale purchase or sale of drugs. Drug licences must not be used for manufacturing medical, diagnostic, pesticide, or foreign drugs.
B. Wholesale Drug Licence: A Wholesale Drug Licence is required for businesses engaged in the wholesale distribution of drugs, including companies, distributors, or authorised Indian agents for domestic or foreign manufacturers. This licence is granted by the CDSCO.
A Manufacturing Licence authorises the production of Allopathic, Ayurvedic, Siddha, Unani drugs, or cosmetic products. This licence is granted by the respective State Licensing Authority.
Obtaining a Drug Licence under the Drugs and Cosmetics Act, 1940 involves a well-defined procedure to ensure compliance with all legal and safety standards. The steps are as follows: